Feuerstein JD, Cheifetz AS. Crohn disease: epidemiology, diagnosis, and management. Mayo Clin Proc. 2017;92:1088–103.

Article  CAS  PubMed  Google Scholar 

Halmos EP, Gibson PR. Dietary management of IBD—insights and advice. Nat Rev Gastroenterol Hepatol. 2015;12:133–46.

Article  CAS  PubMed  Google Scholar 

Hovde Ø, Moum BA. Epidemiology and clinical course of Crohn’s disease: results from observational studies. World J Gastroenterol. 2012;18:1723–31.

Article  PubMed  PubMed Central  Google Scholar 

Nadeem MS, Kumar V, Al-Abbasi FA, Kamal MA, Anwar F. Risk of colorectal cancer in inflammatory bowel diseases. Semin Cancer Biol. 2020;64:51–60.

Article  PubMed  Google Scholar 

Hagymási K, Tulassay Z. Inflammatory bowel disease and colorectal cancer. Orv Hetil. 2006;147:1977–82.

PubMed  Google Scholar 

Quaglio AEV, Grillo TG, De Oliveira ECS, Di Stasi LC, Sassaki LY. Gut microbiota, inflammatory bowel disease and colorectal cancer. World J Gastroenterol. 2022;28:4053–60.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lucafò M, Curci D, Franzin M, Decorti G, Stocco G. Inflammatory bowel disease and risk of colorectal cancer: an overview from pathophysiology to pharmacological prevention. Front Pharmacol. 2021;12: 772101.

Article  PubMed  PubMed Central  Google Scholar 

Saul D, Barros LL, Wixom AQ, Gellhaus B, Gibbons HR, Faubion WA, Kosinsky RL. Cell type-specific induction of inflammation-associated genes in crohn’s disease and colorectal cancer. Int J Mol Sci. 2022. https://doi.org/10.3390/ijms23063082.

Article  PubMed  PubMed Central  Google Scholar 

Wang S, Zhen L, Li X, Fu X, Li P, Zhang D. Search for key genes and functional pathways of ulcerative colitis to colon cancer based on bioinformatics. Front Oncol. 2022;12:857148. https://doi.org/10.3389/fonc.2022.857148. PMID: 35372018; PMCID: PMC8965385.

Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28(1):27–30. https://doi.org/10.1093/nar/28.1.27. PMID: 10592173; PMCID: PMC102409.

Velloso FJ, Trombetta-Lima M, Anschau V, Sogayar MC, Correa RG. NOD-like receptors: major players (and targets) in the interface between innate immunity and cancer. 2019. Biosci Rep. https://doi.org/10.1042/BSR20181709.

Atreya R, Neurath MF. Chemokines in inflammatory bowel diseases. Dig Dis. 2010;28:386–94.

Article  PubMed  Google Scholar 

Bule P, Aguiar SI, Aires-Da-Silva F, Dias JNR. Chemokine-directed tumor microenvironment modulation in cancer immunotherapy. Int J Mol Sci. 2021;22:9804.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zimmerman NP, Vongsa RA, Wendt MK, Dwinell MB. Chemokines and chemokine receptors in mucosal homeostasis at the intestinal epithelial barrier in inflammatory bowel disease. Inflamm Bowel Dis. 2008;14:1000–11.

Article  PubMed  Google Scholar 

Korbecki J, Szatkowska I, Kupnicka P, Żwierełło W, Barczak K, Poziomkowska-Gęsicka I, Wójcik J, Chlubek D, Baranowska-Bosiacka I. The importance of CXCL1 in the physiological state and in noncancer diseases of the oral cavity and abdominal organs. Int J Mol Sci. 2022;23:7151.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mutua V, Gershwin LJ. A review of neutrophil extracellular traps (NETs) in disease: potential Anti-NETs therapeutics. Clin Rev Allergy Immunol. 2021;61:194–211.

Article  CAS  PubMed  Google Scholar 

Seifert L, Werba G, Tiwari S, Giao Ly NN, Alothman S, Alqunaibit D, Avanzi A, Barilla R, Daley D, Greco SH, Torres-Hernandez A, Pergamo M, Ochi A, Zambirinis CP, Pansari M, Rendon M, Tippens D, Hundeyin M, Mani VR, Hajdu C, Engle D, Miller G. The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression. Nature. 2016;532(7598):245–9. https://doi.org/10.1038/nature17403.

Arneth B. Tumor microenvironment. Medicina (Kaunas). 2019;56(1):15. https://doi.org/10.3390/medicina56010015. PMID: 31906017; PMCID: PMC7023392.

Oliver AJ, Lau PKH, Unsworth AS, Loi S, Darcy PK, Kershaw MH, Slaney CY. Tissue-dependent tumor microenvironments and their impact on immunotherapy responses. Front Immunol. 2018;9:70.

Article  PubMed  PubMed Central  Google Scholar 

Ding X, Bin P, Wu W, Chang Y, Zhu G. Tryptophan metabolism, regulatory T cells, and inflammatory bowel disease: a mini review. Mediators Inflamm. 2020;2020:9706140.

Article  PubMed  PubMed Central  Google Scholar 

Li L, Boussiotis VA. The role of IL-17-producing Foxp3+ CD4+ T cells in inflammatory bowel disease and colon cancer. Clin Immunol. 2013;148:246–53.

Article  CAS  PubMed  Google Scholar 

Li J, Byrne KT, Yan F, Yamazoe T, Chen Z, Baslan T, Richman LP, Lin JH, Sun YH, Rech AJ, Balli D, Hay CA, Sela Y, Merrell AJ, Liudahl SM, Gordon N, Norgard RJ, Yuan S, Yu S, Chao T, Ye S, Eisinger-Mathason TSK, Faryabi RB, Tobias JW, Lowe SW, Coussens LM, Wherry EJ, Vonderheide RH, Stanger BZ. Tumor cell-intrinsic factors underlie heterogeneity of immune cell infiltration and response to immunotherapy. Immunity. 2018;49:178-193.e7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bellomo G, Rainer C, Quaranta V, Astuti Y, Raymant M, Boyd E, Stafferton R, Campbell F, Ghaneh P, Halloran CM, Hammond DE, Morton JP, Palmer D, Vimalachandran D, Jones R, Mielgo A, Schmid MC. Chemotherapy-induced infiltration of neutrophils promotes pancreatic cancer metastasis via Gas6/AXL signalling axis. Gut. 2022;71:2284–99.

Article  CAS  PubMed  Google Scholar 

Zha C, Meng X, Li L, Mi S, Qian D, Li Z, Wu P, Hu S, Zhao S, Cai J, Liu Y. Neutrophil extracellular traps mediate the crosstalk between glioma progression and the tumor microenvironment via the HMGB1/RAGE/IL-8 axis. Cancer Biol Med. 2020;17(1):154–168. https://doi.org/10.20892/j.issn.2095-3941.2019.0353. PMID: 32296583; PMCID: PMC7142852.

Balkwill F. TNF-alpha in promotion and progression of cancer. Cancer Metastasis Rev. 2006;25:409–16.

Article  CAS  PubMed  Google Scholar 

Jang D-I, Lee A-H, Shin H-Y, Song H-R, Park J-H, Kang T-B, Lee S-R, Yang S-H. The role of tumor necrosis factor alpha (TNF-α) in autoimmune disease and current TNF-α inhibitors in therapeutics. Int J Mol Sci. 2021;22:2719.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sethi G, Sung B, Aggarwal BB. TNF: a master switch for inflammation to cancer. Front Biosci. 2008;13:5094–107.

Article  CAS  PubMed  Google Scholar 

Wu Y, Zhou BP. TNF-alpha/NF-kappaB/Snail pathway in cancer cell migration and invasion. Br J Cancer. 2010;102:639–44.

Article  CAS  PubMed  PubMed Central  Google Scholar 

DiDonato JA, Mercurio F, Karin M. NF-κB and the link between inflammation and cancer. Immunol Rev. 2012;246:379–400.

Article  PubMed  Google Scholar 

Ravi R, Bedi A. NF-kappaB in cancer–a friend turned foe. Drug Resist Updat. 2004;7:53–67.

Article  CAS  PubMed  Google Scholar 

Wang N, Liu W, Zheng Y, Wang S, Yang B, Li M, Song J, Zhang F, Zhang X, Wang Q, Wang Z. CXCL1 derived from tumor-associated macrophages promotes breast cancer metastasis via activating NF-κB/SOX4 signaling. Cell Death Dis. 2018;9(9):880. https://doi.org/10.1038/s41419-018-0876-3. PMID: 30158589; PMCID: PMC6115425.

Dobrovolskaia MA, Kozlov SV. Inflammation and cancer: when NF-kappaB amalgamates the perilous partnership. Curr Cancer Drug Targets. 2005;5:325–44.

Article  CAS  PubMed  Google Scholar